Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Prosthetic Heart Valves are devices which mimics the function of human heart valves and have a passive mode of functioning; the opening and closing of valves are responses to pressure and flow changes within the heart. GlobalData uses proprietary data and analytics to provide a comprehensive report on the prosthetic heart valves devices market, including market shares of different players within Norway. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the prosthetic heart valves market in Norway was Edwards Lifesciences followed by Medtronic, Abbott Laboratories, Artivion, Corcym, Lepu Medical Technology (Beijing) and Braile Biomedica.
Prosthetic Heart Valves are used for patients who have heart valvular disease and require valve replacement. Prosthetic Heart Valve include both Mechanical Heart Valves and Tissue Heart Valves. Mechanical Heart Valves are generally made of non–physiological materials with a mobile occluder, which is made of rigid materials. Tissue Heart Valves are a combination of tissue and synthetic biomaterials with the tissue itself being flexible.
The value of the prosthetic heart valves devices market within Norway was expected to be over $4m in 2023.
For the latest complete market share analysis of prosthetic heart valves device market in Norway, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.